Assessment of leg ulcers and advances in endovascular treatment
-
Upload
specialistveinhealth -
Category
Health & Medicine
-
view
1.065 -
download
0
Transcript of Assessment of leg ulcers and advances in endovascular treatment
![Page 1: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/1.jpg)
![Page 2: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/2.jpg)
Peripheral Overview
Learning objectives
• Understand common causes and clinical presentation of leg ulcers
• Update on advances in:– endovenous treatment of superficial venous disease– endovascular management of critical limb ischaemia
![Page 3: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/3.jpg)
Peripheral Overview
Ulcer
An ulcer is a defect with loss of epidermis and at least part of the dermis
![Page 4: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/4.jpg)
Peripheral Overview
Causes of lower limb ulceration
• Venous insufficiency (45-60%)• Arterial insufficiency (10-20%)• Diabetes – neuropathic (15-20%)• Lymphoedema• Vasculitis• Infection• Malignancy• Trauma• Drugs• Skin conditions – pyoderma gangrenosum
![Page 5: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/5.jpg)
Peripheral Overview
Pathophysiology Venous ulcer
• Venous ulceration is the end result of sustained ambulatory venous hypertension acting on a dermal microcirculation designed to operate in the presence of low venous pressure
Macrovascular• Valvular reflux
– primary incompetence (elastin/collagen) – Secondary incompetence – post thrombotic
• Muscle pump dysfunction– ageing, MSK and neurological pathologies
• Venous obstruction
![Page 6: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/6.jpg)
Peripheral Overview
Pathophysiology Venous ulcer
Microvascular•Venous stasis and hypoxia•White cell trapping•Pericapillary fibrin cuff – leakage of fibrinogen through pericapillary spaces forms oxygen diffusion barrier•Trapping of growth factors
![Page 7: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/7.jpg)
Peripheral Overview
Pathophysiology Arterial Ulcer
Microvascular•High blood viscosity•Platelet plugging•Endothelial swelling
![Page 8: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/8.jpg)
Peripheral Overview
Pathophysiology Diabetic foot ulcer
![Page 9: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/9.jpg)
Peripheral Overview
Clinical assessment of leg ulcers
FEATURES VENOUS ARTERIAL NEUROPATHICSITE Gaiter area,
commonly medialCircumferential
Pre-tibial, lateral malleolusToes, heel
Pressure areas
PAIN Painless or mild, relieved by elevation
Severe, relieved by dependency
Painless
CHARACTERISTICS Large, irregular marginShallow, sloping edgeSlough with granulation tissue in baseModerate to heavy exudate
Small, irregular shapePunched-out, deepShallow base with necrotic tissueLow exudate unless infected
Regular margins Deep, can probe to bone/sinusSloughy base
![Page 10: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/10.jpg)
Peripheral Overview
Clinical assessment of leg ulcers
FEATURES VENOUS ARTERIAL NEUROPATHICASSOCIATED
FINDINGSHaemosiderin stainingDry skin, eczemaVaricose veins, oedemaPedal pulses present
Thin, shiny, dry skinReduced or no hair on lower legPallor on leg elevationAbsent or weak pedal pulsesDelayed capillary refill
Callous formationLoss of sensation, vibrationWarm foot
![Page 11: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/11.jpg)
Peripheral Overview
Diagnostic testingInvestigation• Punch biopsy• ABI
Imaging modalities• Duplex Ultrasound
• Computerized Tomography Angiography (CTA)
• MR Angiography (MRA)
• Angiogram
![Page 12: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/12.jpg)
Peripheral Overview
ADVANCED VENOUS TREATMENT
![Page 13: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/13.jpg)
Peripheral Overview
Endovenous ablation
• https://youtu.be/JwWlLTzXtdo
![Page 14: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/14.jpg)
Peripheral Overview
Sclerotherapy
![Page 15: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/15.jpg)
Peripheral Overview
Combination endovenous treatment
Advantages•Walk-in, walk-out procedure•Avoid general anaesthetic•Minimal discomfort•Faster return to normal activity•Significantly reduced morbidity
Complications•Saphenous neuralgia•DVT, Heat induced thrombosis•Recurrence•Extravasation of sclerosant•Burn to skin
![Page 16: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/16.jpg)
Peripheral Overview
Mechanicochemical Ablation
Advantages• No need for tumescent anaesthesia• Short procedure time• No chance of nerve injury
• https://youtu.be/ruMuWMQ_HrE
![Page 17: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/17.jpg)
Peripheral Overview
Venaseal
https://youtu.be/IBxtKvG20f0
Medical adhesive for closure of the saphenous vein
Advantages•No sedation required•No need for tumescent anaesthesia•Short procedure time•No chance of nerve injury or burn•No need for compression stockings
![Page 18: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/18.jpg)
Peripheral Overview
ADVANCED ENDOVASCULAR TREATMENT
Common iliacCommon iliac
Internal iliacInternal iliac
ProfundaProfunda
Popliteal arteryPopliteal artery
Posterior tibialPosterior tibial
External iliacExternal iliac
SFASFA
Tibioperoneal trunkTibioperoneal trunk
Anterior tibialAnterior tibial
Peroneal (fibular)Peroneal (fibular)
![Page 19: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/19.jpg)
Peripheral Overview
Diagnostic Test- Angiography
Angiography:• Gold Standard
• X-ray images of blood vessels
• Use of catheters
• Use of contrast agents
• Femoral artery access is common
![Page 20: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/20.jpg)
Peripheral Overview
Extension / ContractionExtension / Contraction1.
TorsionTorsion
2.
CompressionCompression
3.FlexionFlexion 4.
Forces Exerted on SFA
![Page 21: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/21.jpg)
Peripheral Overview
Lesions in SFA
Focal lesionFocal lesion Short proximal nubShort proximal nub
Occlusive diseaseOcclusive disease
Diffuse diseaseDiffuse disease
![Page 22: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/22.jpg)
Peripheral Overview
Popliteal Artery
Note the flexionpoint
occurs above knee
joint not right at joint
location
Knee FlexionKnee Extension
![Page 23: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/23.jpg)
Peripheral Overview
Lesion Types – TASC Guidelines 2007TASC Type A• Single stenosis ≤10 cm in length• Single occlusion ≤5 cm in length
Endovascular therapy is treatment of choiceTASC Type B• Multiple lesions each ≤5cm (stenosis or occlusions)• Single stenosis or occlusion ≤15 cm not involving the infrageniculate popliteal artery• Single or multiple lesion in the absence of continuous tibial vessel to improve
inflow for a distal bypass• Heavily calcified occlusion ≤5 cm long• Single popliteal stenosis
Endovascular therapy is preferred treatmentTASC Type C• Multiple stenoses or occlusions totally >15 cm in length, with or without heavy calcification• Recurrent stenoses or occlusion that need treatment after two endovascular interventions.
Surgery is preferred treatment for good risk patientsTASC Type D• Chronic total occlusion of the common femoral artery or SFA >20 cm in length
involving the popliteal artery• Chronic total occlusion of popliteal artery and proximal trifurcation vessels
Surgery is treatment of choice
Norgen L. Hiatt WR, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).Eur J Vasc Endovasc Surg. 2007:33(suppl1);558-559.
![Page 24: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/24.jpg)
Peripheral Overview
Surgery results
• Gold standard of treatment for TASC C and D• Autologous infrainguinal bypass 60-80% 4 yr patency• Tibial bypass 60% 2 yr patency• Complication 10-15%• Mortality 2-5%• Surveillance required for minimum of 5 yrs for best results
![Page 25: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/25.jpg)
Peripheral Overview
Interventional Procedure
![Page 26: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/26.jpg)
Peripheral Overview
Interventional Procedure Basic Steps
• Vascular access
• Catheter/sheath inserted
• Wire inserted and advanced across lesion
• Balloon Angioplasty
• Stent implantation
![Page 27: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/27.jpg)
Peripheral Overview
Tool Chest for Treatment
Diagnostic
• Sheath– Short– Intermediate – Contralateral
• Wires– 0.035” for catheter
placement– Avoid hydrophillic wires
• Diagnostic catheter – 4-5 fr.– IMA, JR4, AR1, AL1
commonly used
Intervention
• Wires– 0.014”– 0.035” for catheter
placement• Guide Catheter- optional• Balloons
– Low profile– Undersized for pre-dilation
• Stents– BES - iliac– SES- Iliac & SFA
• Alternative Therapies
![Page 28: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/28.jpg)
Peripheral Overview
Arterial Access
Femoral artery – sheath placement Brachial artery – sheath placement
![Page 29: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/29.jpg)
Peripheral Overview
Guide Catheters
DoubleCurve
ShephardsCrook
Single Curve
HockeyStick
Multipurpose
Sizes: 6-7 Fr. Various sizes and shapes used
![Page 30: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/30.jpg)
Peripheral Overview
Treatment: Balloon AngioplastyAngioplasty Balloon• Dilation of narrowed area
• 1:1 balloon size ratio
– Pre-dilation with undersize balloon
Cutting Balloon• 3-4 athertone blades
• Cuts and scores plaque
![Page 31: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/31.jpg)
Peripheral Overview
Treatment: Balloon AngioplastyDrug eluting balloon• Initially developed to treat restenosis
• Emerging evidence for first line use
![Page 32: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/32.jpg)
Peripheral Overview
Treatment: Stents
• Balloon Expandable (BE) Stent
• Self-Expanding (SE) Stents– 1-2 mm larger than the reference balloon diameter– Self tapering
• Covered Stents
Stent selection:
The lesion location influences selection stent
![Page 33: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/33.jpg)
Peripheral Overview
Stent TypesBalloon-expandable:• Stainless Steel
• Cobalt Chromium
• Platinum/Tantalum
Self Expandable:• Nitinol
![Page 34: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/34.jpg)
Peripheral Overview
Iliac Procedure – Ipsilateral Approach
Sheath insame side as lesion. Wire
crosses lesion
Ballooninflation
Stent deployed Stent implanted
![Page 35: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/35.jpg)
Peripheral Overview
Arterial access on the opposite side of the body
as the lesion
Guide catheter guide “up-and-over”
the bifurcation.Wire cross lesion
PTA balloon inserted
and inflated
Stent inserted and deployed
Contralateral Approach
![Page 36: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/36.jpg)
Peripheral Overview
Kissing Balloon technique
![Page 37: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/37.jpg)
Peripheral Overview
Kissing Balloon Technique At Aorto-iliac Bifurcation
AfterBefore Kissing balloon inflation
![Page 38: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/38.jpg)
Peripheral Overview
Pre Post
![Page 39: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/39.jpg)
Peripheral Overview
Infrainguinal angioplasty and stenting
![Page 40: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/40.jpg)
Peripheral Overview
Infrainguinal angioplasty and stenting
![Page 41: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/41.jpg)
Peripheral Overview
Long Term ResultsIliac
Result of PTA + Stenting 98% immediate clinical success
Increase in lumen diameter Abolition of pressure gradient across lesion
90%+ primary patency at 1 year 70%+ primary patency at 4 years
PTA only – restenosis rates ~24-40%
SFA PTA alone has restenosis rate of ~40-50%
PTA + Stenting has restenosis rate of ~20-50% Patency 80% at 12 months, but restenosis rates between 40-50% at
2 yrs. DEB patency >80% at 12 months
Surgical Graft Patency is 60-80% – autogenous at 5 years
Palmaz et al. Cardiovasc Interv RadioloI. 1992:15:291-297.
![Page 42: Assessment of leg ulcers and advances in endovascular treatment](https://reader033.fdocuments.net/reader033/viewer/2022061307/58820d301a28abf05e8b7171/html5/thumbnails/42.jpg)
Peripheral Overview
Potential Procedure Complications
Procedure Related• Access site complications
• Dissection
• Perforation/rupture
• Distal embolisation
• Late aneurysm formation
Device Related• Stent thrombosis
• Stent crush/fracture
• Stent embolization